
Read More
Biocon Gains 2% After Securing 10-Year Pertuzumab Supply Contract in Brazil...
The partnership with Bahiafarma and Bionovis gives Biocon 100% allocation under Brazil's 10-year Pro...

The partnership with Bahiafarma and Bionovis gives Biocon 100% allocation under Brazil's 10-year Pro...

Indian equity markets ended the week sharply lower amid rising crude oil prices, inflation concerns,...

The has given modest returns of 4.41 per cent over the past year. However, it has declined by 11.93 ...

Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood a...

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to stren...

The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private pl...

Following the Asian market, the domestic indices opened on a positive note on Thursday. The markets ...

On Wednesday, the benchmark indices remained under pressure post the repo rate hike. RBI hiked the k...

At noon on Tuesday, the core equity indices, i.e. Sensex and Nifty 50 were trading on the lower side...

On Thursday around noon, the core equity indices i.e., Sensex and Nifty 50 were trading higher by a ...